Cascade Testing After Research Loses the Exemption

If a relative took part in a research study, a genetic fault was found, and that finding is the reason you have now been referred for testing, your position under the insurance rules is not quite what you might assume. Research results are given a special exemption in the UK. But the NHS cascade test you are being offered is a clinical test, not a research one — and that means the research exemption does not carry across to your result, even though it was a research finding that started the whole chain.

For most people this changes nothing at the point of a life insurance application, because a predictive genetic test result cannot be asked for anyway. But the status of your result is different from your relative's, and there is one narrow situation where the difference genuinely bites. This is the subtlest provision in the whole Code on Genetic Testing and Insurance, so it is worth setting out carefully rather than glossing over.

Below is what cascade testing on the NHS actually is, what the research exemption says, why your test sits outside it, and the one place the distinction matters.

Two different protections, easy to confuse

The Code on Genetic Testing and Insurance actually offers two separate shields, and people blur them together. The first is the general protection for predictive test results: an insurer will not ask you to take a predictive genetic test, and will not ask for or use the result of one, when you apply for cover. This has a single carved-out exception, described further down.

The second is a distinct, broader carve-out for research. Results that arise in the course of a research study sit outside the system altogether. The reason is deliberate policy: if people feared that taking part in genetic research could later cost them insurance, fewer would take part, and the studies the NHS and universities rely on would suffer. So research results are kept off the table without qualification.

The trouble starts when a research finding in one person becomes the reason another person is tested clinically. That is exactly what cascade testing does.

What cascade testing is

Cascade testing is the process of working outwards through a family once a specific inherited fault has been identified in one member. If a pathogenic variant is confirmed in one relative, the NHS offers to test their close relatives for that same, known fault — parents, siblings and children first, then wider relatives if the fault is found closer in. It is efficient and targeted, because everyone is being tested for one specific thing rather than screened blindly.

Crucially, cascade testing runs through the NHS clinical genetics service. You are seen in a clinic, counselled, and tested as a patient. That clinical setting is what determines the status of your result — and it is a different setting from the research study your relative took part in, even when the fault being looked for is identical.

The research exemption, stated plainly

The Code's research provision is short and, in substance, reads to this effect:

A genetic test result obtained in the course of research does not have to be disclosed and will not be asked for by an insurer, so that concern about insurance does not deter people from taking part in research.

Read it closely and you can see why it is so protective: it turns on how the result was obtained, not on what the result says. A research result is exempt full stop. It is a stronger and simpler protection than the one for clinical predictive results, which — as we will see — has an exception attached to it.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

Why your cascade test is clinical, not research

Here is the crux. The research exemption belongs to the result that was obtained in the research study. That is your relative's result. When your relative's research finding leads the NHS to test you, your test is done clinically, as ordinary NHS care. Your result was not obtained in the course of research — it was obtained in a genetics clinic. So the research exemption does not attach to your result.

This surprises people, understandably. It feels as though the research protection ought to flow down the family alongside the fault. It does not. The exemption is about the circumstances in which a particular test was carried out, and your circumstances are clinical. The trigger came from research; your test did not.

What you still have is the general protection. Your cascade result is a predictive genetic test, taken while you are well to assess future risk, and predictive results cannot be asked for or used on an ordinary life application. So you are not left exposed — you have simply moved from the research shield to the predictive-test shield. For most conditions and cover levels those two shields lead to the same place: the result stays off the form. If you are weighing up timing, our piece on whether to buy cover before genetic testing works through the ordering, and it is usually less urgent in the UK than imported advice suggests.

When the distinction actually bites

If both shields usually reach the same result, when does it matter which one you are standing behind? In one narrow but real situation.

The general protection for predictive results has a single listed exception. For Huntington's disease, and only where the total life cover applied for is more than £500,000, an insurer is currently permitted to ask about a predictive test result. That is the one place the predictive-test shield has a hole in it.

The research exemption does not have that hole. A Huntington's result obtained purely through research would remain exempt even above £500,000, because the research carve-out is unconditional. So consider someone applying for a large amount of life cover whose Huntington's status is known:

• if that status came from an NHS cascade test, it is a clinical predictive result, and above £500,000 of life cover it falls within the one situation where it could be asked for;
• if the very same information had come purely from research participation, the research exemption would keep it off the form even at that level.

That is the whole of the difference, and it is why the cascade-versus-research distinction is not merely academic for the one condition on the approved list. For everything else, and for life cover at ordinary levels, both routes currently end with the result not being askable.

What this means for you in practice

Step back from the edge case and the practical position for most readers is reassuring. Your cascade result is protected on an ordinary life application. You do not have to volunteer it, and the insurer cannot ask for it. What you must still do is answer honestly the questions you are asked — about your own symptoms, diagnoses, investigations and treatment — because clinical care that follows a test is ordinary medical history even when the gene result behind it is protected.

Keep a clear record of how your result was obtained, because status matters here and memories blur. If a decision ever looks as though it leaned on a protected result, there is a defined complaints route with real deadlines, which we map in challenging a genetics decision. And if you are worried more broadly that a family history question could unravel a future claim, whether a claim can be refused over family history explains how the law actually separates a careless answer from a dishonest one.

It also helps to keep the underlying risk in proportion. A known fault in the family is a reason to be informed, not a verdict. The plain arithmetic in your real chance of dying before 65 is a steadier reference point than a single frightening word on a clinic letter, and the family history, inherited risk and the odds hub gathers the rest of the picture.

It is also worth remembering that a cascade test can come back negative. Being offered the test does not mean you are expected to carry the fault, only that your family's genetics make it sensible to check. A negative result closes the question for you, and for your own children, in a way that itself can feel like a large piece of certainty gained rather than lost. Either way, the insurance position described above is the same before you are tested, while you wait for the result, and afterwards, because the protection covers the test itself, not just a particular outcome.

Getting cover in place

If the reason you are reading this is that you want protection in place for the people who depend on you, that is a sound instinct, and the cascade result is not the barrier it might feel like. You can get life insurance quotes and let an FCA-authorised broker structure the application correctly — level term cover is the common shape for family protection — so your medical facts are answered accurately while the predictive result stays where the Code keeps it. Doing nothing has its own cost: our account of what a family faced when a parent died with no life insurance sets out, in real timescales, what going without actually means.

Scotland and Northern Ireland

The Code on Genetic Testing and Insurance is an industry-wide agreement covering insurers across the United Kingdom, and the Consumer Insurance (Disclosure and Representations) Act 2012 applies UK-wide, so the research exemption, the predictive-test protection and the Huntington's threshold work the same way in Scotland and Northern Ireland as in England and Wales.

What can differ is the clinical machinery: how NHS clinical genetics services are organised in each nation, and how cascade testing is arranged locally. Those affect how and when you are seen, not the insurance status of the result once you have it. Wherever you are tested in the UK, a cascade test is a clinical test, and the research exemption stays with the research result that started it.

Frequently asked questions

Are research genetic results protected from insurers?

Yes. The Code on Genetic Testing and Insurance says results obtained in the course of research need not be disclosed and will not be asked for. The protection is deliberate, because insurance anxiety would otherwise reduce participation in the studies the NHS and universities rely on. It is a broad, unconditional exemption that turns on how the result was obtained.

What if a relative's research result sends me for testing?

Your own test is then an NHS clinical cascade test rather than a research one, so the research exemption does not carry across to you. It is still a predictive genetic test, so it cannot be asked for on an ordinary life application, but its status under the Code has changed from research-exempt to predictive-protected, which are not identical.

Why does the distinction matter?

Because the exemption for research is broader than the protection for predictive tests generally. A research result sits outside the system entirely, while a clinical predictive result sits inside a Code that has a listed exception — Huntington's disease above £500,000 of life cover — and financial thresholds that could be revisited at a future review. For ordinary cover, both routes currently keep the result off the form.